54 devices · GMDN 64787
SARS-CoV-2 antigen IVD kits use rapid immunochromatographic tests (ICT) to detect viral proteins from COVID-19 in clinical samples like nasal swabs. These point-of-care or lab-based tests provide quick results—typically within minutes—helping identify active infections for timely clinical decisions.
These devices are regulated as in vitro diagnostics (IVDs) and must meet performance standards for accuracy and reliability. They are often supplied as kits with swabs, buffers, and test strips, designed for use by trained professionals or in controlled settings, excluding self-testing at home.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.